Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 148 of the 149 references it cites were found in a registry or an index.

Comprehensive Review on Alzheimer’s Disease: Causes and Treatment

Open access

Abstract

Alzheimer’s disease (AD) is a disorder that causes degeneration of the cells in the brain and it is the main cause of dementia, which is characterized by a decline in thinking and independence in personal daily activities. AD is considered a multifactorial disease: two main hypotheses were proposed as a cause for AD, cholinergic and amyloid hypotheses. Additionally, several risk factors such as increasing age, genetic factors, head injuries, vascular diseases, infections, and environmental factors play a role in the disease. Currently, there are only two classes of approved drugs to treat AD, including inhibitors to cholinesterase enzyme and antagonists to N-methyl d-aspartate (NMDA), which are effective only in treating the symptoms of AD, but do not cure or prevent the disease. Nowadays, the research is focusing on understanding AD pathology by targeting several mechanisms, such as abnormal tau protein metabolism, β-amyloid, inflammatory response, and cholinergic and free radical damage, aiming to develop successful treatments that are capable of stopping or modifying the course of AD. This review discusses currently available drugs and future theories for the development of new therapies for AD, such as disease-modifying therapeutics (DMT), chaperones, and natural compounds.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules25245789

Cites

148 of 148 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The physiological structure of the brain and neurons in (a) healthy brain and (b) Alzheimer’s disease (AD) brain.
Figure 1 The physiological structure of the brain and neurons in (a) healthy brain and (b) Alzheimer’s disease (AD) brain.CC BY · PubMed Central
Figure 2 The risk factors for Alzheimer’s disease.
Figure 2 The risk factors for Alzheimer’s disease.CC BY · PubMed Central
Figure 3 The pathway for the synthesis and transportation of acetylcholine between presynaptic and postsynaptic nerve terminals.
Figure 3 The pathway for the synthesis and transportation of acetylcholine between presynaptic and postsynaptic nerve terminals.CC BY · PubMed Central
Figure 4 The chemical structures of approved drugs for symptomatic treatment of AD (tacrine 1, donepezil 2, rivastigmine 3, galantamine 4, and memantine 5) and disease-modifying compounds that entered clinical trials (semagacestat 6, avagacestat 7, tarenflurbil 8, lanabecestat 9, verubecestat 10, atabecestat 11, umibecestat 12, methylene blue 13, tideglusib 14, and saracatinibin 15).
Figure 4 The chemical structures of approved drugs for symptomatic treatment of AD (tacrine 1, donepezil 2, rivastigmine 3, galantamine 4, and memantine 5) and disease-modifying compounds that entered clinical trials (semagacestat 6, avagacestat 7, tarenflurbil 8, lanabecestat 9, verubecestat 10, atabecestat 11, umibecestat 12, methylene blue 13, tideglusib 14, and saracatinibin 15).CC BY · PubMed Central
Figure 5 The chemical structures of different chaperone molecules: Mizoribine 16, EC3016 17, Avrainvillamide 18, Epolaztaene 19, MKT-077 20, YM-01 21, JG-98 22, Radicicol 23, Geldanamycin 24, 17-AAG 25, Pochoxime C (OS47720) 26, R55 27, and OT1001 28.
Figure 5 The chemical structures of different chaperone molecules: Mizoribine 16, EC3016 17, Avrainvillamide 18, Epolaztaene 19, MKT-077 20, YM-01 21, JG-98 22, Radicicol 23, Geldanamycin 24, 17-AAG 25, Pochoxime C (OS47720) 26, R55 27, and OT1001 28.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

18 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

4 retracted

Show all 149 references

Research works printed but not linked: 4

  1. Kumar, A., Sidhu, J., and Goyal, A. (2020). Alzheimer Disease. StatPearls, StatPearls Publishing. Available online: https://www.ncbi.nlm.nih.gov/books/NBK499922/.
  2. Singh, R., and Sadiq, N.M. (2020). Cholinesterase Inhibitors. StatPearls, StatPearls Publishing. Available online: https://www.ncbi.nlm.nih.gov/books/NBK544336/.
  3. Kuns, B., Rosani, A., and Varghese, D. (2020). Memantine. StatPearls, StatPearls Publishing. Available online: https://www.ncbi.nlm.nih.gov/books/NBK500025/.
  4. Kumar, A., and Sharma, S. (2020). Donepezil. StatPearls, StatPearls Publishing. Available online: https://www.ncbi.nlm.nih.gov/books/NBK513257/.

Cited by

See all 2,789

Metadata

Authors
Breijyeh, Z., & Karaman, R.
Affiliations
Al-Quds University (PS)
Corresponding author
Karaman, Rafik
Venue
Molecules
Publisher
MDPI AG
Published
2020-12-08
Volume
25
Issue
24
Pages
5789
ISSN
1420-3049 (ISSN-L)
OpenAlex
W3112948680
Cited by
2,789
References
149
Citations by year
2026: 418 · 2025: 708 · 2024: 733 · 2023: 541 · 2022: 310 · 2021: 79
FWCI
29.74
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords
Alzheimer's disease, dementia, cholinergic hypothesis, amyloid hypothesis, risk factors, cholinesterase inhibitors, NMDA receptor antagonists, tau protein, amyloid-beta, neuroinflammation, oxidative stress, disease-modifying therapy, molecular chaperones, natural compounds, drug development
MeSH terms
Alzheimer Disease, Animals, Disease Susceptibility, Humans, Risk Factors, Severity of Illness Index, Biomarkers, Amyloid beta-Peptides, tau Proteins, Risk Assessment, Disease Management, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. https://app.cochat.ai/papers/10.3390/molecules25245789
The paper
Breijyeh, Z., & Karaman, R. (2020). Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules. https://doi.org/10.3390/molecules25245789

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.